Using translational in vitro-in vivo modeling to improve drug repurposing outcomes for inhaled COVID-19 therapeutics
Madison Stoddard, Lin Yuan, Arijit Chakravarty
doi: https://doi.org/10.1101/2021.03.11.21253375
Madison Stoddard
1Fractal Therapeutics Inc, Cambridge, MA, USA
Lin Yuan
1Fractal Therapeutics Inc, Cambridge, MA, USA
Arijit Chakravarty
1Fractal Therapeutics Inc, Cambridge, MA, USA

Data Availability
The work describes a mathematical methodology based on publicly available data. All data used in the work was sourced from prior publications.
Posted March 12, 2021.
Using translational in vitro-in vivo modeling to improve drug repurposing outcomes for inhaled COVID-19 therapeutics
Madison Stoddard, Lin Yuan, Arijit Chakravarty
medRxiv 2021.03.11.21253375; doi: https://doi.org/10.1101/2021.03.11.21253375
Subject Area
Subject Areas
- Addiction Medicine (269)
- Allergy and Immunology (549)
- Anesthesia (134)
- Cardiovascular Medicine (1747)
- Dermatology (172)
- Emergency Medicine (310)
- Epidemiology (10779)
- Gastroenterology (583)
- Genetic and Genomic Medicine (2933)
- Geriatric Medicine (286)
- Health Economics (531)
- Health Informatics (1918)
- Health Policy (833)
- Hematology (290)
- HIV/AIDS (627)
- Medical Education (299)
- Medical Ethics (86)
- Nephrology (321)
- Neurology (2780)
- Nursing (150)
- Nutrition (431)
- Oncology (1454)
- Ophthalmology (440)
- Orthopedics (172)
- Otolaryngology (255)
- Pain Medicine (190)
- Palliative Medicine (56)
- Pathology (379)
- Pediatrics (864)
- Primary Care Research (333)
- Public and Global Health (5338)
- Radiology and Imaging (1002)
- Respiratory Medicine (722)
- Rheumatology (329)
- Sports Medicine (278)
- Surgery (327)
- Toxicology (47)
- Transplantation (149)
- Urology (125)